Skip to main content
. 2021 Mar 8;7(3):mgen000545. doi: 10.1099/mgen.0.000545

Table 3.

The size, position and integration sites of all 16 prophages within all samples in this study, also included is the percentage nucleotide similarity to any Sakai prophages

Prophage

detected

Gene 5′ to prophage

Gene 3′ to prophage

Size (bp) in sample A

Size (bp) in sample B

Size (bp) in sample C

Size (bp) in sample D

(% similarity /%coverage) to Sakai prophages

Position in sample A

Position in sample B

Position in sample C

Position in sample D

1

lexA

aphA

22 035

22 035

22 034

22 036

/

403 708–425 743

403 729–425 764

4 03 712–4 25 746

403 708–425 744

2∗

tRNA-Thr (cgt)†

prgR

26 826

26 823

26 823

26 821

/

1 101 413–1 128 239

1 101 440–1 128 263

1 101 421–1 128 244

1 101 414–1 128 235

3

ybhC

ybhB

38 095

38 095

38 096

38 095

Sp3 (99 %/100 %)

1 697 277–1 735 372

1 697 420–1 735 515

1 697 397–1 735 493

1 697 388–1 735 483

4

yccA

tRNA-Ser (tga)

48 257

48 277

48 265

48 263

Sp4 (99 %/100 %)

1 967 370–2 015 627

1 967 513–2 015 790

1 967 491–2 015 756

1 967 481–2 015 744

5

potC

potB

47 889

47 679

47 879

47 896

Sp6 (99 %/100 %)

2 283 891–2 331 780

2 284 054–2 331 733

2 284 019–2 331 898

2 284 012–2 331 908

6

roxA

phoQ

10 436

10 436

10 436

10 436

/

2 337 022–2 347 458

2 336 975–2 347 411

2 337 140–2 347 576

2 337 150–2 347 586

7

icd

caeB

40 992

40 991

40 992

40 991

Sp8 (99 %/100 %)

2 356 230–2 397 222

2 356 183–2 397 174

2 356,348–2 397 340

2 356 358–2 397 349

8

ompW

rspR

145 151

144 981

145 040

53 636

/

2 495 566–2 640 717

2 495 518–2 640 499

2 495 685–2 640 725

2 495 693–2 549 329

A

hipA

ydeP

/

/

/

28 513

/

/

/

/

2 589 222–2 617 735

9

trpA

rspA

59 339

59 340

59 322

59 863

/

2 918 047–2 977 386

2 917 834–2 977 174

2 918 061–2 977 383

2 855 169–2 915 032

10

yodB

tRNA-Ser (cga)†

43 681

43 694

43 684

43 690

Sp14 (99 %/98 %)

3 370 042–3 413 723

3 369 847–3 413 541

3 370 056–3 413 740

3 307 170–3 350 860

11 (stx2c)

yeeA

tnpA

55 650

56 910

55 652

55 655

/

3 457 661–3 513 311

3 456 222–3 513 132

3 457 677–3 513 329

3 394 797–3 450 452

12

yehV

yehV†

45 720

45 725

45 732

45 719

/

3 654 766–3 700 486

3 654 584–3 700 309

3 654 782–3 700 514

3 591 904–3 637 623

13 (stx2a)

yfdC

argW

60 239

60 237

60 239

60 242

/

3 948 563–4 008 802

3 948 386–4 008 623

3 948 591–4 008 830

3 885 700–3 945 942

14

argW

lacY

8233

8233

8233

8233

Sp16 (100 %/100 %)

4 009 234–4 017 467

4 009 055–4 017 288

4 009 262–4 017 495

3 946 374–3 954 607

15

ssrA

alpA

22 107

22 103

22 098

22 106

Sp17 (99 %/99 %)

4 294,770–4 316 877

4,294,584–4 316 687

4 294 801–4 316 899

4 231 915–4 254 021

∗Refers to prophages that appear to be compound prophages (i.e. two or more prophages that are sequential, with intact integrase genes).

†Refers to the end in which the Integrase gene (IntA) is located.